Table 5. Treatment and outcomes of RPI-KD, KD (i.e., KD without RPI), and bacterial RPA
| Variables | RPI-KD | KD | Bacterial RPA | References |
| Abx, single (%) | 100.0 | (n = 11) | – | 100.0 | (n = 36) | [12] |
| Abx, multiple (%) | 54.5 | (n = 22) | – | 55.9 | (n = 34) | [13] |
| Surgery (%) | 0.0 | (n = 11) | – | 16.7 | (n = 36) | [12] |
| 9.1 | (n = 22) | – | 14.7 | (n = 34) | [13] |
| Length of stay (days) | 11.11) | (n = 10) | 6.7 | (n = 20) | 8.6 | (n = 16) | [11] |
| 7.01) | (n = 130) | 3.0 | (n = 20,657) | – | [16] |
| Medical cost ($) | 19,7731) | (n = 130) | 8,645 | (n = 20,657) | – | [16] |
| Coronary artery | 20.0 | (n = 10) | 5.0 | (n = 20) | – | [11] |
| complications (%) | 0.0 | (n = 10) | 3.7 | (n = 267) | – | [15] |
| 1.1 | (n = 130) | 3.8 | (n = 20,657) | – | [16] |
P < 0.01.
RPI-KD: Kawasaki disease with retropharyngeal inflammation; KD: Kawasaki disease; RPA: retropharyngeal abscess: Abx: antibiotics.